title: CD4+ T cell and eosinophil adhesion is mediated by specific ICAM-3 ligation and results in eosinophil activation.
abstract: T cells and eosinophils, which are found in close proximity in asthmatic lungs, express many surface receptors that are counterligands. These data suggest that direct interactions between these cell types could play an important role in regulating airway inflammation in asthma. We examined the effect of selective adhesion between counterligands on human eosinophils and CD4+ T cells to determine 1) the existence of specific adhesive interactions and 2) if augmented specific adhesion to CD4+ T cells also caused augmented secretion of leukotriene C4 (LTC4) from eosinophils. A new method for binding of human CD4+ T cells to microwell plates was developed, which allowed for specific quantitative assessment of eosinophil adhesion to individual CD4+ T cells in culture. Adhesion of CD4+ T cells to eosinophils was minimal in unstimulated cells but increased after activation of T cells by PMA. Augmented adhesion was regulated substantially through binding of ICAM-3 and only minimally by ICAM-1. We further evaluated whether this specific adhesion up-regulated stimulated secretion of LTC4 from eosinophils. Adhesion with CD4+ T cells augmented eosinophil secretion of LTC4 caused by FMLP plus cytochalasin. Blockade of ICAM-3, as well as ICAM-1, inhibited completely the augmented secretion of eosinophil LTC4. We demonstrate that eosinophils and CD4+ T cells are capable of ligand-specific adhesion that is mediated predominantly by ICAM-3 ligation and that this binding causes augmented eosinophil secretion.
authors.affiliation: Department of Medicine, University of Chicago, IL 60637, USA.
authors.forename: I S
authors.initials: IS
authors.lastname: Douglas
authors.forename: A R
authors.initials: AR
authors.lastname: Leff
authors.forename: A I
authors.initials: AI
authors.lastname: Sperling
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology; D015703:Antigens, CD / Q000096:biosynthesis; D000943:Antigens, Differentiation; D018845:CD11 Antigens / Q000096:biosynthesis; D018821:CD18 Antigens / Q000096:biosynthesis; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D002448:Cell Adhesion / Q000276:immunology; D015815:Cell Adhesion Molecules / Q000096:biosynthesis / Q000276:immunology* / Q000378:metabolism*; D002478:Cells, Cultured; D004804:Eosinophils / Q000276:immunology* / Q000378:metabolism*; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000096:biosynthesis; D017997:Leukotriene C4 / Q000378:metabolism; D008024:Ligands; D008213:Lymphocyte Activation; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology
chemical_list: D000276:Adjuvants, Immunologic; D015703:Antigens, CD; D000943:Antigens, Differentiation; D018845:CD11 Antigens; D018821:CD18 Antigens; D015815:Cell Adhesion Molecules; C065289:ICAM2 protein, human; C483616:ICAM3 protein, human; D008024:Ligands; D018799:Intercellular Adhesion Molecule-1; D017997:Leukotriene C4; D009240:N-Formylmethionine Leucyl-Phenylalanine